Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials?

被引：9

作者：

Januzzi, James L., Jr. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Cardiol Div, 32 Fruit St,Yawkey 5984, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA USA

来源：

JACC-HEART FAILURE | 2018年 / 6卷 / 07期

关键词：

biomarker; heart failure; outcomes;

D O I：

10.1016/j.jchf.2018.02.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：570 / 572

页数：3

共 50 条

[21] Biomarkers and surrogate endpoints in clinical trials
Fleming, Thomas R.
Powers, John H.
STATISTICS IN MEDICINE, 2012, 31 (25) : 2973 - 2984
[22] CLINIMETRIC PROPERTIES OF CFTR BIOMARKERS: TIME FOR PROMOTION TO SURROGATE ENDPOINT?
Kent, L.
De Boeck, C.
Sermet-Gaudelus, I
PEDIATRIC PULMONOLOGY, 2011, : 293 - 293
[23] Surrogate endpoint trials: Benefit and pitfalls for clinical decision making
Bucher, H. C.
INTERNIST, 2008, 49 (06): : 681 - 687
[24] Nonparametric recovery of interblock information in clinical trials with a surrogate endpoint
El-Moalem, H
Sen, PK
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1998, 72 (1-2) : 185 - 205
[25] Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials
Ibrahim, Nasrien E.
Gaggin, Hanna K.
Konstam, Marvin A.
Januzzi, James L., Jr.
CIRCULATION-HEART FAILURE, 2016, 9 (09)
[26] It is time for consistency in the use of biomarkers in heart failure clinical trials
Januzzi, James L., Jr.
Ibrahim, Nasrien E.
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (01) : 90 - 91
[27] GFR slope as a surrogate endpoint for CKD progression in clinical trials
Inker, Lesley A.
Chaudhari, Juhi
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (06): : 581 - 590
[28] Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials
Wolfson, Julian
Gilbert, Peter
BIOMETRICS, 2010, 66 (04) : 1153 - 1161
[29] Can Outpatient Worsening Heart Failure Serve as an Endpoint in Clinical Trials of Transthyretin Amyloidosis?
Cheng, Richard K.
Leedy, Douglas
Ruberg, Frederick L.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (07) : 762 - 765
[30] Comparison of Outcome Adjudication by Investigators and by a Central Endpoint Committee (CEC) in Heart Failure Trials: Experience of the Shift Heart Failure Study
Benoit, T. Y. L.
Sendon, Jose Lopez
Borer, Jeffrey S.
De Sa, Esteban Lopez
Lerebours, Guy
Varin, Claire
de Montigny, Aurelie
Komajda, Michel
CIRCULATION, 2019, 140

← 1 2 3 4 5 →